News Releases & Research Results New SATREPS Projects for FY 2024 under AMED International Collaborative Research Program

News Releases & Research Results

Japan Agency for Medical Research and Development (AMED, President: MISHIMA Yoshinao) announced the provisional selection *1 of two new projects in the Infectious Diseases Control research area concerning “Research on measures to address infectious diseases control attuned to the needs of developing countries” for the Fiscal Year 2024 Science and Technology Research Partnership for Sustainable Development (SATREPS) program under AMED's International Collaborative Research Program.

The SATREPS is a Japanese government program that promotes international joint research. The program has been structured as a collaboration among AMED, the Japan Science and Technology Agency (JST) and the Japan International Cooperation Agency (JICA), supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Ministry of Foreign Affairs (MOFA). Based on the needs of developing countries, AMED and JICA cooperate to promote international joint research targeting global issues with an objective of future utilization of research outcomes. Implemented through collaboration with Official Development Assistance (ODA), the objectives of the program is to acquire new knowledge and technology that lead to the resolution of global issues and the advance of science and technology, and through this process, to create innovations. International joint research under this program also aims to enhance the research and development capabilities of developing countries, and to help create sustainable research systems which could address and resolve issues related to Sustainable Development Goals (SDGs).

For FY2024, AMED called for project proposals from researchers in Japan in the infectious diseases control research area and began to accept proposals on August 22nd, 2023. A total of 15 eligible proposals was received by the close of applications on October 23rd, 2023. Evaluation committee reviewed the proposal documents with ex-ante evaluation criterias including ODA perspectives established by the committee. AMED provisionally selected 2 new projects based on the committee evaluation results and will begin the support after the conclusion of contracts. One of the new projects is the first international joint research between Japan and Republic of India in the infectious disease control research area under SATREPS program.

The SATREPS *2 programs in other three research fields‐Environment/Energy, Bioresources, and Disaster Prevention and Mitigation are managed by a collaboration of JST and JICA, supported by MEXT and MOFA.

*1 Provisional selection
Before starting a project , an international agreement needs to be concluded between MOFA and the government of the counterpart country regarding implementation of the project, followed by an agreement on the details of Technical Cooperation between JICA and the research counterpart(s) in the counterpart country. However, depending on the situation in the counterpart country or the result of discussion of details with the research counterpart, a project may result in modifications or even termination. For this reason, the status of these projects at this stage is “provisional selection".
Science and Technology Research Partnership for Sustainable Development

The project for assessing genetic diversity of Vibrio cholerae using cloud computing and developing potential therapeutics against cholera”
Republic of India
(IIDA Tetsuya, Professor, Research Institute for Microbial Diseases, Osaka University)

“Project for the Sustainable Control of Zoonotic Malaria through an Integrated Approach”
(KANEKO Osamu, Professor, Institute of Tropical Medicine, Nagasaki University)

* Projects are listed in alphabetical order based on the name of the principal investigator.


Department of International Strategy
Japan Agency for Medical Research and Development (AMED)
1-7-1 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan
Tel: 03-6870-2216
E-mail: amed-satreps"AT" "at" with "@".)


Last updated 04/18/24